Development Document for Final Effluent Limitations Guidelines, New Source Performance Standards and Pretreatment Standards for the Pharmaceutical Manufacturing Point Source Category.
This document presents the findings of a study of the Pharmaceutical Manufacturing Point Source Category for the purpose of finalizing effluent limitations guidelines for existing and new point sources and to establish pretreatment standards for existing and new dischargers to publicly owned treatment works to implement Sections 301, 304, 306, 307, 308, and 501 of the Clean Water Act (the Federal Water Polution Control Act Amendments of 1972, 33 USC 1251 et. seq., as amended by the Clean Water Act of 1977, P.L 95-217 (the "Act")).
|Office of Water|
|Effluent Guidelines Division|
|Office of Water Regulations and Standards|
|Hund, Frank H.|
|Background Cost-Related Document|